Lapatinib: In Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer

By Curran Monique P.  

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1411-1422

Adis International

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

By Croxtall Jamie D.   McKeage Kate  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 363-380

Adis International

Access to resources Recommend Favorite

Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer

By Montemurro Filippo   Rossi Valentina   Geuna Elena   Valabrega Giorgio   Martinello Rossella   Milani Andrea   Aglietta Massimo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2143-2156

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations

By Carlson Robert W.   Hudis Clifford A.   Pritchard Kathy I.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 10, 2006-11 ,pp. : 971-979

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms

By Cowles Verne E.  

Clinical Drug Investigation, Vol. 32, Iss. 9, 2012-09 ,pp. : 593-601

Adis International

Access to resources Recommend Favorite